Pascale Soyeux

1.4k total citations
23 papers, 799 citations indexed

About

Pascale Soyeux is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Pascale Soyeux has authored 23 papers receiving a total of 799 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Surgery and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Pascale Soyeux's work include Bladder and Urothelial Cancer Treatments (9 papers), Prostate Cancer Treatment and Research (9 papers) and Urinary Tract Infections Management (5 papers). Pascale Soyeux is often cited by papers focused on Bladder and Urothelial Cancer Treatments (9 papers), Prostate Cancer Treatment and Research (9 papers) and Urinary Tract Infections Management (5 papers). Pascale Soyeux collaborates with scholars based in France, United States and Germany. Pascale Soyeux's co-authors include Alexandre de la Taille, Pascale Maillé, Yves Allory, Francis Vacherot, Stéphane Terry, Laurent Salomon, C.C. Abbou, Fabien Saint, Dominique Chopin and Laurence Kheuang and has published in prestigious journals such as Cancer, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Pascale Soyeux

21 papers receiving 788 citations

Peers

Pascale Soyeux
Zuli Yang China
Philip Levy Ho United States
Kan Wu China
Sung Soo Kim South Korea
Jeffery N. Myers United States
Kelly L. Mueller United States
K Mafune Japan
Zuli Yang China
Pascale Soyeux
Citations per year, relative to Pascale Soyeux Pascale Soyeux (= 1×) peers Zuli Yang

Countries citing papers authored by Pascale Soyeux

Since Specialization
Citations

This map shows the geographic impact of Pascale Soyeux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascale Soyeux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascale Soyeux more than expected).

Fields of papers citing papers by Pascale Soyeux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascale Soyeux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascale Soyeux. The network helps show where Pascale Soyeux may publish in the future.

Co-authorship network of co-authors of Pascale Soyeux

This figure shows the co-authorship network connecting the top 25 collaborators of Pascale Soyeux. A scholar is included among the top collaborators of Pascale Soyeux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascale Soyeux. Pascale Soyeux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vacherot, Francis, et al.. (2025). Targeting Aggressive Prostate Carcinoma Cells with Mesothelin-CAR-T Cells. Biomedicines. 13(5). 1215–1215.
2.
Bartier, S., Pascale Soyeux, E. Huet, et al.. (2023). Apalutamide Prevents SARS-CoV-2 Infection in Lung Epithelial Cells and in Human Nasal Epithelial Cells. International Journal of Molecular Sciences. 24(4). 3288–3288. 1 indexed citations
3.
Firlej, Virginie, Pascale Soyeux, E. Huet, et al.. (2022). Overexpression of Nucleolin and Associated Genes in Prostate Cancer. International Journal of Molecular Sciences. 23(9). 4491–4491. 8 indexed citations
4.
Moktefi, Anissa, Ariane Jolly, Pierre de la Grange, et al.. (2022). The Neuropilin-1/PKC axis promotes neuroendocrine differentiation and drug resistance of prostate cancer. British Journal of Cancer. 128(5). 918–927. 10 indexed citations
5.
Masson-Lecomte, A., Pascale Maillé, Sílvia Pineda, et al.. (2019). CD8+ Cytotoxic Immune Infiltrate in Non-Muscle Invasive Bladder Cancer: A Standardized Methodology to Study Association with Clinico-Pathological Features and Prognosis. Bladder Cancer. 5(2). 159–169. 7 indexed citations
6.
Moktefi, Anissa, Damien Pouessel, Jing Liu, et al.. (2018). Reappraisal of HER2 status in the spectrum of advanced urothelial carcinoma: a need of guidelines for treatment eligibility. Modern Pathology. 31(8). 1270–1281. 26 indexed citations
7.
Destouches, Damien, Stéphane Terry, C. Marchand, et al.. (2016). Implication of NPM1 phosphorylation and preclinical evaluation of the nucleoprotein antagonist N6L in prostate cancer. Oncotarget. 7(43). 69397–69411. 17 indexed citations
8.
Terry, Stéphane, Nathalie Nicolaı̈ew, Pascale Soyeux, et al.. (2015). Clinical value of ERG, TFF3, and SPINK1 for molecular subtyping of prostate cancer. Cancer. 121(9). 1422–1430. 29 indexed citations
10.
Terry, Stéphane, Pascale Maillé, Laurence Kheuang, et al.. (2013). Cross Modulation between the Androgen Receptor Axis and Protocadherin-PC in Mediating Neuroendocrine Transdifferentiation and Therapeutic Resistance of Prostate Cancer. Neoplasia. 15(7). 761–IN22. 43 indexed citations
11.
Caldéraro, Julien, Sandra Rebouissou, Leanne de Koning, et al.. (2013). PI3K/AKT pathway activation in bladder carcinogenesis. International Journal of Cancer. 134(8). 1776–1784. 78 indexed citations
12.
Caldéraro, Julien, Julien Moroch, Gaëlle Pierron, et al.. (2012). SMARCB1/INI1 inactivation in renal medullary carcinoma. Histopathology. 61(3). 428–435. 85 indexed citations
13.
Ploussard, Guillaume, Stéphane Terry, Pascale Maillé, et al.. (2010). Class III β-Tubulin Expression Predicts Prostate Tumor Aggressiveness and Patient Response to Docetaxel-Based Chemotherapy. Cancer Research. 70(22). 9253–9264. 121 indexed citations
14.
Azoulay, Sandy, Stéphane Terry, Nanor Sirab, et al.. (2008). Comparative expression of Hedgehog ligands at different stages of prostate carcinoma progression. The Journal of Pathology. 216(4). 460–470. 60 indexed citations
15.
Descazeaud, A., Mark A. Rubin, Matthias D. Hofer, et al.. (2008). BPH Gene Expression Profile Associated to Prostate Gland Volume. Diagnostic Molecular Pathology. 17(4). 207–213. 20 indexed citations
16.
Giton, Frank, Alexandre de la Taille, Yves Allory, et al.. (2008). Estrone sulfate (E1S), a prognosis marker for tumor aggressiveness in prostate cancer (PCa). The Journal of Steroid Biochemistry and Molecular Biology. 109(1-2). 158–167. 25 indexed citations
17.
Paule, Bernard, Stéphane Terry, Laurence Kheuang, et al.. (2007). The NF-κB/IL-6 pathway in metastatic androgen-independent prostate cancer: new therapeutic approaches?. World Journal of Urology. 25(5). 477–489. 64 indexed citations
18.
Saint, F., Patrick Maillé, Dimitri Vordos, et al.. (2003). Urinary IL-2 assay for monitoring intravesical bacillus calmette-guérin (BCG) response of superficial bladder cancer during induction course and maintenance therapy. European Urology Supplements. 2(1). 191–191. 4 indexed citations
19.
Saint, Fabien, Pascale Maillé, Dimitri Vordos, et al.. (2003). Urinary IL‐2 assay for monitoring intravesical bacillus Calmette‐Guérin response of superficial bladder cancer during induction course and maintenance therapy. International Journal of Cancer. 107(3). 434–440. 53 indexed citations
20.
Saint, Fabien, Jean Jacques Patard, Pascale Maillé, et al.. (2002). PROGNOSTIC VALUE OF A T HELPER 1 URINARY CYTOKINE RESPONSE AFTER INTRAVESICAL BACILLUS CALMETTE-GUERIN TREATMENT FOR SUPERFICIAL BLADDER CANCER. The Journal of Urology. 364–367. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026